Andrulis IL - Search Results

1

Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry.

Figueiredo JC, Knight JA, Briollais L, Andrulis IL, Ozcelik H. Figueiredo JC, et al. Among authors: andrulis il. Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):583-91. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15066923

2

Multiplex PCR-SSCP for simultaneous screening for mutations in several exons of p53.

Ozçelik H, Andrulis IL. Ozçelik H, et al. Among authors: andrulis il. Biotechniques. 1995 May;18(5):742-4. Biotechniques. 1995. PMID: 7619467 No abstract available.

3

Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer.

Mousses S, Ozçelik H, Lee PD, Malkin D, Bull SB, Andrulis IL. Mousses S, et al. Among authors: andrulis il. Hum Mol Genet. 1995 Jun;4(6):1089-92. doi: 10.1093/hmg/4.6.1089. Hum Mol Genet. 1995. PMID: 7655464

4

Heteroduplex and protein truncation analysis of the BRCA1 185delAG mutation.

Ozcelik H, Antebi YJ, Cole DE, Andrulis IL. Ozcelik H, et al. Among authors: andrulis il. Hum Genet. 1996 Sep;98(3):310-2. doi: 10.1007/s004390050212. Hum Genet. 1996. PMID: 8707299

5

MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma.

Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL, Attisano L. Eppert K, et al. Among authors: andrulis il. Cell. 1996 Aug 23;86(4):543-52. doi: 10.1016/s0092-8674(00)80128-2. Cell. 1996. PMID: 8752209 Free article.

6

New Ontario familial breast cancer registry to facilitate genetic and epidemiologic studies.

Andrulis IL, Boyd NF, Sutherland H. Andrulis IL, et al. Can Fam Physician. 1997 May;43:949-50. Can Fam Physician. 1997. PMID: 9154367 Free PMC article. No abstract available.

7

p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.

Done SJ, Arneson NC, Ozçelik H, Redston M, Andrulis IL. Done SJ, et al. Among authors: andrulis il. Cancer Res. 1998 Feb 15;58(4):785-9. Cancer Res. 1998. PMID: 9485035

8

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group.

Andrulis IL, Bull SB, Blackstein ME, Sutherland D, Mak C, Sidlofsky S, Pritzker KP, Hartwick RW, Hanna W, Lickley L, Wilkinson R, Qizilbash A, Ambus U, Lipa M, Weizel H, Katz A, Baida M, Mariz S, Stoik G, Dacamara P, Strongitharm D, Geddie W, McCready D. Andrulis IL, et al. J Clin Oncol. 1998 Apr;16(4):1340-9. doi: 10.1200/JCO.1998.16.4.1340. J Clin Oncol. 1998. PMID: 9552035

9

Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers.

Ozçelik H, To MD, Couture J, Bull SB, Andrulis IL. Ozçelik H, et al. Among authors: andrulis il. Int J Cancer. 1998 Jul 3;77(1):1-6. doi: 10.1002/(sici)1097-0215(19980703)77:1<1::aid-ijc1>3.0.co;2-y. Int J Cancer. 1998. PMID: 9639385

10

Low levels of expression of an inhibitor of cyclin-dependent kinases (CIP1/WAF1) in primary breast carcinomas with p53 mutations.

Ozçelik H, Mousses S, Andrulis IL. Ozçelik H, et al. Among authors: andrulis il. Clin Cancer Res. 1995 Aug;1(8):907-12. Clin Cancer Res. 1995. PMID: 9816061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

482 results

Search Page

Filters